Actual Medicinal Product (AMP) Darunavir 400mg tablets (Amarox Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Does not require any special storage conditions.
- Provenance
-
This compatibility recommendation is derived from Prezista 400mg tablets (Janssen-Cilag Ltd).
- Generic
- Darunavir
- Formulation
- Darunavir 400mg tablets
-
Darunavir
-
Darunavir 400mg tablets
-
Darunavir 400mg tablets (Amarox Ltd)
-
-